About Us
Technology
Our Pipeline
Partnerships
News
Menu
About Us
Technology
Our Pipeline
Partnerships
News
Contact Us
About Us
Technology
Our Pipeline
Partnerships
News
Menu
About Us
Technology
Our Pipeline
Partnerships
News
Immunyx Has Developed Technologies for Neutrophil Modulation
Activated Neutrophil Targeted Nanoparticles
Small Molecule Modulators of Neutrophil Toxicity
FDA Approved Off Patent Modulators of Neutrophil Toxicity
Neutrophil Targeted mRNA Delivery and Sequences
Contact Us
Immunyx strives to improve disease treatment. If you’re interested in our mission we would love to hear from you.
Name
Email
Message
Send Message
210 W. 90th Street New York NY 10024